She was once the world's youngest self-made female billionaire. Now Elizabeth Holmes, founder of the blood-testing startup Theranos, stands accused of leading a massive fraud, and lying to investors, doctors, and patients about the capabilities of her technology. If convicted, she faces up to 20 years in prison. But Elizabeth may be able to sway a jury with her charisma, highly unusual defense strategy and the fact that key evidence has gone missing. John Carreyrou broke the Theranos scandal. Now he’ll take you into the courtroom as he examines Silicon Valley’s fake it-til-you-make it culture, and the case against Holmes.
https://www.threeuncannyfour.com/show/bad-blood/
Gesamtlänge aller Episoden: 11 hours 11 minutes
episode 12: Episode 12: The Verdict
Host John Carreyrou and reporter Emily Saul revisit the drama of Elizabeth Holmes’s guilty verdict, dissect its meaning, and discuss sentencing. And a surprise guest comes on the show. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 11: Episode 11: Investors
With a conference call, a magazine interview and a doctored pharmaceutical report, Elizabeth Holmes convinced a small group of very wealthy investors to put hundreds of millions of dollars in her unproven blood-testing startup. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 10: Episode 10: Tyler and George
One of the enduring mysteries of the Theranos scandal is how Elizabeth Holmes managed to turn former Secretary of State George Shultz against his own grandson. New information sheds light on how she did it. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 9: Episode 9: The Military
Elizabeth Holmes wowed investors with claims that Theranos was working for the U.S. military. But the truth was that her repeated attempts to land contracts with the Department of Defense had gone nowhere. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 8: Episode 8: Fake Demos
Elizabeth Holmes wowed investors, board members and journalists with live, in-person demonstrations that made it seem like her blood-testing machine worked. But most of these demos were faked. Behind the scenes, the blood samples were tested either manually or on third-party lab equipment. It's an astoundingly bold deception that was enabled by a software application Sunny Balwani wrote. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 7: Episode 7: The ADVIA Project
In the summer of 2013, as a deadline to launch in Walgreens stores loomed and Theranos was running out of money, Elizabeth Holmes and Sunny Balwani put in motion a covert plan to hack third-party blood-testing machines to hide the limitations of Theranos' technology. Learn more about your ad choices. Visit podcastchoices.com/adchoices
We Return Next Week
We'll be back with new full episodes on October 21st. Here's a little preview of what we've been working on. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 6: This Week in Court #4: PR Over Patient Care
Host John Carreyrou and reporter Emily Saul discuss prosecutors' introduction of private texts between Elizabeth and Sunny, the testimony of retired general James Mattis, and the trial's most important witness so far: former lab director Adam Rosendorff, who said Theranos prioritized PR and fundraising over patient care. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 6: Episode 6: Holmes and the Media
For two years, Elizabeth Holmes enjoyed the type of glowing media coverage most entrepreneurs can only dream of. But then she gave one interview too many—an interview with The New Yorker’s Ken Auletta that planted the seeds of her downfall. Learn more about your ad choices. Visit podcastchoices.com/adchoices
episode 5: Episode 5: Fake it 'Till You Make It
Elizabeth Holmes is the latest in a long line of Silicon Valley entrepreneurs who’ve hyped and overpromised — sometimes to the point of outright lying. It’s that culture, as much as Holmes herself, that's on trial. Learn more about your ad choices. Visit podcastchoices.com/adchoices